Dr. Reddy's Laboratories has made an investment of Rs 650 crore in Aurigene Oncology (AOL) and AOL has allotted 9,70,14,896 equity shares of Rs 10 each at a premium of Rs 57 to the company on May 23, 2024.
The fund infused by the company into AOL will be further invested in Aurigene Pharmaceutical Services (APSL), a wholly-owned subsidiary of AOL and step down wholly owned subsidiary of the company, to support the capex and working capital requirements of APSL.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
